test

ANDREW TIMPSON

@Silverarc Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NUVLNuvalent Inc
Recent Activity
Decreased -20.24%
8.54%
$37.998M
371,441 shares@ $102.3 avg price
RNAAvidity Biosciences Inc
Recent Activity
Decreased -8.14%
4.91%
$21.842M
475,555 shares@ $45.93 avg price
ERASErasca Inc
Recent Activity
Decreased -11.13%
4.26%
$18.964M
6.946M shares@ $2.73 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
Decreased -13.11%
2.75%
$12.227M
167,110 shares@ $73.18 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -18.22%
2.58%
$11.444M
901,129 shares@ $12.7 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
Decreased -0.62%
2.21%
$9.839M
35,774 shares@ $275.03 avg price
CCCCC4 Therapeutics Inc
Recent Activity
Decreased -10.04%
1.67%
$7.398M
1.298M shares@ $5.71 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -16.78%
1.23%
$5.434M
455,082 shares@ $11.94 avg price
BHVNBiohaven Ltd
Recent Activity
Decreased -0.43%
1.12%
$4.975M
99,566 shares@ $49.97 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Decreased -61.32%
1.11%
$4.929M
145,000 shares@ $33.99 avg price